Progression of ventricular wall thickening after liver transplantation for familial amyloidosis

Transplantation

Volumn 64, Issue 1, 1997, Pages 74-80

  Dubrey, Simon W ^a,b   Davidoff, Ravin ^a   Skinner, Martha ^a   Bergethon, Peter ^a   Lewis, David ^c   Falk, Rodney H ^a,d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ADULT; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; GRAFT REJECTION; HEART FUNCTION TEST; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ADULT; AMYLOIDOSIS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FAMILY HEALTH; FEMALE; GRAFT REJECTION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUTATION; PREALBUMIN; VENTRICULAR FUNCTION, LEFT;

EID: 0030805834     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199707150-00014     Document Type: Article

References (37)

1. Benson MD. Amyloidosis. In: Scriver CR, Beaudet AK, Sly WS, Valle D, ed. The metabolic and molecular bases of inherited disease.'New York: McGraw-Hill, 1995: 4159.
2. Simms RW, Prout MN, Cohen AS. The epidemiology of AL and AA amyloidosis. Balliere's Clin Rheumatol 1994; 8: 627.
3. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45.
4. Falcao De Freitas A, Barbedo A. Conduction disturbances in 190 patients with familial amyloidotic polyneuropathy (Andrade's type). Adv Cardiol 1978; 21: 206.
5. Olofsson BO, Andersson R, Furberg B. Atrioventricular and intraventricular conduction in familial amyloidosis with polyneuropathy. Acta Med Scand 1980; 208: 77.
6. Eriksson P, Backman C, Bjerle P, Eriksson A, Holm S, Olofsson BO. Non-invasive assessment of the presence and severity of cardiac amyloidosis: a study in familial amyloidosis with polyneuropathy. Br Heart J 1984; 52: 321.
7. Hongo M, Ikeda S. Echocardiographic assessment of the evolution of amyloid heart disease: a study with familial amyloid polyneuropathy. Circulation 1986; 73: 249.
8. Holmgren G, Ericzon BG, Groth CG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993; 341: 1113.
9. 30). Clin Genet 1991; 40: 242.
10. Skinner M, Lewis WD, Jones LE, et al. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med 1994; 120: 133.
11. Steen L, Holmgren G, Suhr O, Wikstrom L, Ericzon BG, Groth CG. World wide survey of liver transplantations in patients with familial amyloidotic polyneuropathy. Amyloid Int J Exp Clin Invest 1994; 1: 138.
12. Parrilla P, Lopez-Andreu FR, Ramirez P, et al. Familial amyloidotic polyneuropathy type 1 (Andrade's disease): a new indication for liver transplantation. Transplantation 1994; 57: 473.
13. Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 1996; 47: 944.
14. Criteria Committee, New York Heart Association, Inc. Diseases of the heart and blood vessels: nomenclature and criteria for diagnosis, 6th ed. Boston: Little, Brown and Co., 1964: 114.
15. Falk RH. Cardiac amyloidosis. Prog Cardiol 1989; 2: 143.
16. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45.
17. Backman C, Olofsson BO. Echocardiographic features in familial amyloidosis with polyneuropathy. Acta Med Scand 1983; 214: 273.
18. Hongo M, Ikeda S. Echocardiographic assessment of the evolution of amyloid heart disease: a study with familial amyloid polyneuropathy. Circulation 1986; 73: 249.
19. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450.
20. Grose R, Strain J, Yipintosoi T. Right ventricular function in valvular heart disease: relation to pulmonary pressure. J Am Coll Cardiol 1983; 2: 225.
21. Klein AL, Cohen GI. Doppler echocardiographic assessment of constrictive pericarditis, cardiac amyloidosis, and cardiac tamponade. Cleve Clin J Med 1992; 59: 278.
22. Xie G-Y, Berk MR, Smith MD, DeMaria AN. Relation of Doppler transmitral flow patterns to functional status in congestive heart failure. Am Heart J 1996; 131: 766.
23. Benson MD, Uemichi T. Transthyretin amyloidosis. Amyloid Int J Exp Clin Invest 1996; 3: 44.
24. Ando Y, Ando E, Tanaka Y, et al. De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation. Transplantation 1996; 62: 1037.
25. Westermark P, Sletten K, Johansson B, Cornwell GG. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Soc USA 1990; 87: 2843.
26. Dwulet FE, Benson MD. Primary structure of an amyloid prealbumin and its plasma precursor in a heredofamilial polyneuropathy of Swedish origin. Proc Natl Acad Sci USA 1984; 81: 694.
27. Thylen C, Wahlquist J, Haettner E, Sandgren O, Holmgren G, Lundgren E. Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met 30 mutation. EMBO J 1993; 12: 743.
28. Wallace MR, Dwulet FE, Conneally M, Benson MD. Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis. J Clin Invest 1986; 78: 6.
29. Saraiva MJM, Birken S, Costa PP, Goodman DS. Amyloid fibril protein in familial amyloidotic polyneuropathy Portuguese type. J Clin Invest 1984; 74: 104.
30. Atkison P, Joubert J, Barron A, et al. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. Lancet 1995; 345: 894.
31. Hibi S, Misawa A, Tamai M, et al. Severe rhabdomyolysis associated with tacrolimus. Lancet 1995; 346: 702.
32. Dwahan A, Mack DR, Langnas AN, Shaw BW, Vanderhoof JA. Immunosuppressive drugs and hypertrophic cardiomyopathy. Lancet 1995; 345: 1644.
33. Dollinger MM, Plevris JM, Chauhan A, MacGilchrist AJ, Finlayson NDC, Hayes PC. Tacrolimus and cardiotoxicity in adult liver transplant recipients [Letter]. Lancet 1995; 346: 507.
34. Natazuka T, Ogawa R, Kizaki T, et al. Immunosuppressive drugs and hypertrophic cardiomyopathy. Lancet 1995; 345: 1644.
35. Lipkin GW, Tucker B, Giles M, Raine AE. Ambulatory blood pressure and left ventricular mass in cyclosporin and non cyclosporin treated renal transplant recipients. J Hyperten 1993; 11: 439.
36. Textor SC, Canzanello VJ, Taler SJ, et al. Cyclosporin induced hypertension after transplantation. Mayo Clin Proc 1994; 69: 1182.
37. Jarrett JT, Lansbury PT Jr. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie. Cell 1993; 73: 1055.